Kuala Lumpur - Delayed Quote MYR

Pentamaster Corporation Berhad (7160.KL)

2.4400

+0.0100

+(0.41%)

As of 12:29:38 PM GMT+8. Market Open.

Stock market today: S&P 500, Dow, Nasdaq futures slip ahead of huge week of Big Tech earnings, economic data

US futures slip slightly with investors focused on Big Tech earnings for the week ahead.

Yahoo Finance 1 hour ago

YM=F

ES=F

NQ=F
Asian Shares Post Cautious Start, Futures Drop: Markets Wrap

(Bloomberg) -- Asian shares had a modest start to the week as investors awaited progress in US trade negotiations with the region and signs of further stimulus from China before taking risky bets.Most Read from BloombergWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesNewsom Says California Is Now the World’s Fourth-Biggest EconomyAt Bryn Mawr, a Monumental Plaza Traces the Steps of Black HistoryBackyard Micro-Flats Aim to Ease South Africa’s Housing CrisisLos Angeles Downgraded to AA-

Bloomberg 57 minutes ago

TM

TOYOF

8301.T
India's Reliance rises as telecom, retail strength brightens outlook

Shares of the Indian billionaire Mukesh Ambani-led conglomerate rose as much as 3.4% to their highest since late-October and were the top percentage gainers on India's benchmark Nifty 50 index. "Stock valuation has turned attractive," Antique Broking said in a note. Reliance posted a fourth-quarter profit above expectations on Friday, helped by a boost in its telecom business and retail arm.

Reuters 1 hour ago

^YH309
China's Ant Group forays into brokerage business with $362 million Bright Smart buy

China's Ant Group is buying a controlling stake in Hong Kong-based brokerage Bright Smart Securities & Commodities Group for about $362 million, marking the fintech firm's first acquisition of a securities brokerage licence. Ant Group agreed to buy a 50.55% stake in Bright Smart for HK$2.81 billion ($362.26 million), the firms said in a joint statement. Bright Smart chairman Yip Mow Lum is selling 857.98 million shares at HK$3.28 each to Ant Group's Wealthiness and Prosperity Holding, which will be required to make an unconditional mandatory cash offer for all the issued shares.

Reuters 2 hours ago

^HSI
Saia First Quarter 2025 Earnings: Misses Expectations

Saia ( NASDAQ:SAIA ) First Quarter 2025 Results Key Financial Results Revenue: US$787.6m (up 4.3% from 1Q 2024). Net...

Simply Wall St. 16 hours ago

SAIA
Toyota considers investing in potential $42 billion buyout of key supplier

TOKYO (Reuters) -Toyota Motor said it is exploring the possibility of investing in a potential buyout of key parts supplier Toyota Industries - a buyout that reportedly could cost $42 billion. "We are currently exploring various possibilities, including partial investment," the automaker said in a filing with the Tokyo stock exchange on Saturday following reports about the possible buyout. Bloomberg News reported on Friday that Toyota Chairman Akio Toyoda and his founder family have proposed acquiring Toyota Industries in a possible 6 trillion yen ($42 billion) deal.

Reuters 22 hours ago

TM

TYIDY
Succeeding With This Stock May Require Investors to Out-Buffett Warren Buffett. Here's Why.

Warren Buffett's Berkshire Hathaway sold more stock than it bought in 2024, so it likely raised some eyebrows when the company revealed its position in Constellation Brands (NYSE: STZ). This could mean that Berkshire needs to lean more into Buffett's strategy and not less.

Motley Fool yesterday

STZ

^GSPC
Akeso survival data for ivonescimab misses expectations, STAT says

While Akeso (AKESF) and Summit Therapeutics’ (SMMT) ivonescimab, a rival to Merck’s (MRK) Keytruda, won approval in China this week, the data on patient survival did not meet analyst expectations, Jonathan Wosen of STAT reports. In its submission to regulators, Akeso included data on patient survival, disclosing that an interim analysis following 157 patient deaths found that participants on ivonescimab had a roughly 22% reduced risk of death, with a hazard ratio of 0.784, a company spokesperson

TipRanks yesterday

BNTX

SMMT

MRK
China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz

The major averages were mixed near noon following several days of gains as investors process the latest batch of earnings reports, including a notable one from a big tech bellwether. Optimism over easing U.S.-China trade tensions, particularly with China reportedly considering tariff exemptions for certain American products, is also being weighed, though President Trump said he would consider it a “total victory” if the U.S. has high tariffs of 20%-50% on foreign nations a year from now, accordi

TipRanks yesterday

LOW

TMUS

GOOG
BMO downgrades Saia, says challenges will take time to overcome

As previously reported, BMO Capital downgraded Saia (SAIA) to Market Perform from Outperform with a price target of $285, down from $455. Saia appears to have struggled to balance growth and profitability amid its network expansion, which has been challenged by the freight recession, and the firm believes challenges will take time to overcome, the analyst tells investors. However, the firm believes results reflect Saia-specific challenges and that concerns over industry pricing power “appear mis

TipRanks yesterday

SAIA

XPO
Tesla Vs. BYD: EV Giants' Earnings Diverge Wildly, But Both Stocks Soar

BYD's Q1 net income doubled vs. a year earlier, passing Tesla for the first time. Tesla earnings dived, but Elon Musk is still bullish on robotaxis. Both stocks soared.

Investor's Business Daily yesterday

TSLA

BYDDY
2 Buffett Stocks You Can Buy During a Market Crash and Hold Forever

The market crash that followed President Donald Trump's tariff announcement on April 2 was a disaster for short-term-minded investors. For those of us who like to buy and hold dividend-paying stocks for years, though, market crashes create relative bargains out of stocks that previously seemed a little too pricey. Warren Buffett took control of Berkshire Hathaway in 1965, and since then, shares of the holding company have produced a 19.9% average annual return.

Motley Fool yesterday

STZ

KO
Q1 2025 Saia Inc Earnings Call

Q1 2025 Saia Inc Earnings Call

Thomson Reuters StreetEvents yesterday

SAIA
Saia Inc (SAIA) Q1 2025 Earnings Call Highlights: Record Revenue Amidst Challenging Conditions

Despite achieving record first-quarter revenue, Saia Inc (SAIA) faces operational challenges with a deteriorating operating ratio and decreased earnings per share.

GuruFocus.com yesterday

SAIA
Toyota Chairman Proposes Record Buyout of Its Supplier at $42 Billion Valuation

(Bloomberg) -- Toyota Motor Corp. Chairman Akio Toyoda has proposed a buyout of Toyota Industries Corp., people familiar with the matter said, seeking to consolidate his grip on Japan’s biggest business empire as a wave of merger and acquisition activity roils the country.Most Read from BloombergWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesNewsom Says California Is Now the World’s Fourth-Biggest EconomyBackyard Micro-Flats Aim to Ease South Africa’s Housing CrisisAt Bryn Mawr, a Mo

Bloomberg 2 days ago

TM

TOYOF

TYIDF
Galloway Capital builds 3% WW stake, pushes for debt deal amid bankruptcy rumors

Investing.com – Galloway Capital Partners is urging WW International Inc (NASDAQ:WW) to avoid Chapter 11 bankruptcy, after disclosing a 2.87% stake in the embattled weight management company. The firm’s Chief Investment Officer, Bruce Galloway, told Investing.com that Weight Watchers still has solid fundamentals and does not meet the criteria for insolvency, making a bankruptcy filing both unwarranted and damaging to equity holders.

Investing.com 2 days ago

WW

RGS
Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today

Both U.S.-based Summit Therapeutics (NASDAQ: SMMT) and BioNTech (NASDAQ: BNTX) were down significantly, plunging 36.1% and 15.4%, respectively, in Friday's trading. The severe moves were likely related to a Chinese rival in the PD-1/VEGF bispecific antibody area, Akeso (OTC: AKES.F), receiving FDA approval for a cancer drug that utilizes similar technology, as well as an additional approval in China. As a result, Akeso shares were up 11.7% on Friday.

Motley Fool 2 days ago

SMMT

BNTX

AKESF
Top Stock Reports for Walmart, Toyota Motor & Boston Scientific

Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Toyota Motor Corp. (TM) and Boston Scientific Corp. (BSX), as well as a micro-cap stock Autoscope Technologies Corp. (AATC).

Zacks 2 days ago

WMT

TM

BSX
Saia’s shares sag 30% as tariffs tank demand, exacerbate growing pains

Saia’s shares are getting punished as the company’s ambitious growth efforts have been derailed by a trade war. The post Saia’s shares sag 30% as tariffs tank demand, exacerbate growing pains appeared first on FreightWaves.

FreightWaves 2 days ago

SAIA
Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China

MIAMI, April 25, 2025--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today noted that Akeso, Inc. (Akeso, HKEX Code: 9926.HK) announced that ivonescimab was approved by the Chinese Health Authorities, the National Medical Products Administration (NMPA), for a second indication based on the results of the Phase III clinical trial, HARMONi-2 or AK112-303. HARMONi-2 evaluated monotherapy ivonescimab against monotherapy pembrolizumab in patients with locally advanced or

Business Wire 2 days ago

SMMT

Performance Overview

Return	7160.KL	FTSE Bursa Malaysia KLCI (^KLSE)
YTD	-41.35%	-7.53%
1-Year	-41.26%	-3.58%
3-Year	-26.40%	-4.92%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Pentamaster Corporation Berhad (7160.KL)

Related News

Stock market today: S&P 500, Dow, Nasdaq futures slip ahead of huge week of Big Tech earnings, economic data

Asian Shares Post Cautious Start, Futures Drop: Markets Wrap

India's Reliance rises as telecom, retail strength brightens outlook

China's Ant Group forays into brokerage business with $362 million Bright Smart buy

Saia First Quarter 2025 Earnings: Misses Expectations

Toyota considers investing in potential $42 billion buyout of key supplier

Succeeding With This Stock May Require Investors to Out-Buffett Warren Buffett. Here's Why.

Akeso survival data for ivonescimab misses expectations, STAT says

China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz

BMO downgrades Saia, says challenges will take time to overcome

Tesla Vs. BYD: EV Giants' Earnings Diverge Wildly, But Both Stocks Soar

2 Buffett Stocks You Can Buy During a Market Crash and Hold Forever

Q1 2025 Saia Inc Earnings Call

Saia Inc (SAIA) Q1 2025 Earnings Call Highlights: Record Revenue Amidst Challenging Conditions

Toyota Chairman Proposes Record Buyout of Its Supplier at $42 Billion Valuation

Galloway Capital builds 3% WW stake, pushes for debt deal amid bankruptcy rumors

Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today

Top Stock Reports for Walmart, Toyota Motor & Boston Scientific

Saia’s shares sag 30% as tariffs tank demand, exacerbate growing pains

Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China

Performance Overview